Saturday, June 1, 2013: 12:00 PM-3:15 PM
The Role Of Vitamin D In Optic Neuritis
Jodie M Burton, MD, MSc, FRCPC, University of Calgary;
Jessie Trufyn, BSc, University of Calgary;
Cheslia Tung, BSc candidate, University of Calgary;
Misha Eliasziw, PhD, Tufts University;
Fiona Costello, MD, FRCPC, University of Calgary
Autologous Haematopoietic Stem Cell Transplant In Patients With Neuromyelitis Optica
Jodie M Burton, MD, MSc, FRCPC, University of Calgary;
Jan Storek, PhD, MD, FRCPC, University of Calgary;
Peter Duggan, MD, FRCPC, University of Calgary;
Fiona Costello, MD, FRCPC, University of Calgary;
Donna Genest, RN, University of Calgary;
Robert Bell, MD, FRCPC, University of Calgary;
Luanne Metz, MD, FRCPC, University of Calgary
Teriflunomide Efficacy and Safety Analyses: Results From TEMSO and TOWER
Mark Freedman, MD, University of Ottawa;
Christian Confavreux, MD, University Claude Bernard, Lyon, France;
Tomas Olsson, MD, Karolinska Institute;
Giancarlo Comi, MD, University Vita-Salute San Raffaele;
Aaron Miller, MD, Mount Sinai School of Medicine;
Jerry Wolinsky, MD, University of Texas Health Science Center;
Ludwig Kappos, MD, University Hospital, Basel Neurology, Basel, Switzerland;
Hadj Benzerdjeb, MD, Sanofi;
Deborah Dukovic, MS, Sanofi;
Philippe Truffinet, MD, Sanofi;
Paul O'Connor, MD, University of Toronto
The Effect Of IV MP (Methylprednisolone) On Glucose and Blood Pressure In MS Patients
Malcolm H Gottesman, MD, Winthrop University Hospital;
Patricia A Patrick, DrPH, Winthrop University Hospital;
Denise Cheng, RN, Winthrop University Hospital;
Eileen Boylan, RN, Winthrop University Hospital;
Abigail McNall, FNP, Winthrop University Hospital;
Sharon Friedman-Urevich, DNP, Winthrop University Hospital;
Shicong Ye, MD, Winthrop University Hospital;
Johanna Guardado, RN, Winthrop University Hospital
Viral and Genetic Risk Factors For Pediatric Neuromyelitis Optica
Sirisha Grandhe, BA, University of California, San Francisco;
Jennifer Graves, MD, PhD, University of California, San Francisco;
Ellen M Mowry, MD, University of California, San Francisco;
Lauren Krupp, MD, Stony Brook University Medical Center;
Tanuja Chitnis, MD, Massachusetts General Hospital;
Eluen A Yeh, MD, Hospital for Sick Children;
Nancy Kuntz, MD, Ann & Robert H. Lurie Children's Hospital of Chicago;
Jayne Ness, MD, Children's Hospital Alabama;
Anita L Belman, MD, Stony Brook University Medical Center;
Maria Milazzo, NP, Stony Brook University Medical Center;
Mark Gorman, MD, Boston Children's Hospital;
Bianca Weinstock-Guttman, MD, University of Buffalo;
Moses Rodriguez, MD, Mayo Clinic;
Marc Patterson, MD, Mayo Clinic;
Judith A James, MD, Oklahoma Medical Research Foundation, University of Oklahoma;
Emmanuelle Waubant, MD, PhD, University of California, San Francisco
Selective Deletion of S1P5 Receptors Reduces Remyelination in the Curprizone Model
Audrey Gray, MS, EMD Serono Research Institute;
Dongzi Yu, MS, EMD Serono Research Institute;
Dan Crawford, PhD, EMD Serono Research Institute;
Frederic Bernard, PhD, EMD Serono Research Institute;
Ursula Boschert, PhD, EMD Serono Research Institute;
Tammy Dellovade, PhD, EMD Serono Research Institute;
Danielle Graham, PhD, EMD Serono Research Institute
Pragmatic Exercise For People With MS: A Randomized Controlled Trial
John M Saxton, PhD, University of East Anglia;
Anouska Carter, MSc, Sheffield Hallam University;
Amanda Daley, PhD, University of Birmingham;
Liam Humphreys, MSc, Sheffield Hallam University;
Nicky Snowdon, MSc, Sheffield Hallam University;
Nicola Woodroofe, PhD, Sheffield Hallam University;
Jane Petty, BSc (Hons), London;
Andrea Roalfe, MSc, University of Birmingham;
Basil Sharrack, MD, Sheffield Teaching Hospitals NHS Foundation Trust
Risk factors for transverse myelitis compared with multiple sclerosis, neuromyelitis optica, and other neurologic disorders in pediatric patients
Kelley M Weinfurtner, B.A., University of California-San Francisco;
Jennifer Graves, MD, PhD, University of California, San Francisco;
Ellen M Mowry, MD, University of California, San Francisco;
Lauren Krupp, MD, Stony Brook University Medical Center;
Tanuja Chitnis, MD, Massachusetts General Hospital;
E Ann Yeh, MD, Hospital for Sick Children, University of Toronto;
Moses Rodriguez, MD, Mayo Clinic;
Jayne Ness, MD, Children's Hospital Alabama;
Anita L Belman, MD, Stony Brook University Medical Center;
Marc Patterson, MD, Mayo Clinic;
Mark Gorman, MD, Boston Children's Hospital;
Bianca Weinstock-Guttman, MD, State University of New York at Buffalo, Buffalo;
Judith A James, MD, Oklahoma Medical Research Foundation, University of Oklahoma;
Emmanuelle Waubant, MD, PhD, University of California, San Francisco
Profiling Of Secondary Progressive Multiple Sclerosis By Multicolor Flow Cytometry
Lauren W Collison, Ph.D., Opexa Therapeutics, Inc.;
Chris L Ayers, Ph.D., Opexa Therapeutics, Inc.;
Jordan L Harrell, M.B.E., Opexa Therapeutics, Inc.;
Jaye L Thompson, Ph.D., Opexa Therapeutics, Inc.;
Don G Healey, Ph.D., Opexa Therapeutics, Inc.
Consequences Of Different Definitions Of Confirmed Disability Progression
Ron Hashmonay, MD, Novartis Pharmaceuticals Corporation;
Niklas Bergvall, PhD, Novartis Pharma AG;
Nikolaos Sfikas, PhD, Novartis Pharma AG;
Peter Chin, MD, Novartis Pharmaceuticals Corporation;
Philipp von Rosenstiel, MD, Novartis Pharma AG
Walking and Cognition, But Not Symptoms, Correlate With Dual Task Cost Of Walking In MS
Robert W Motl, PhD, University of Illinois at Urbana-Champaign;
Jacob J Sosnoff, PhD, University of Illinois at Urbana-Champaign;
Deirdre Dlugonski, BS, University of Illinois at Urbana-Champaign;
Lara A Pilutti, PhD, University of Illinois at Urbana-Champaign;
Rachel E Klaren, BS, University of Illinois at Urbana-Champaign;
Brian M Sandroff, MS, University of Illinois at Urbana-Champaign
Recurrent Falls In Older Adults With MS
Jacob J Sosnoff, PhD, University of Illinois at Urbana-Champaign;
Swathi Balantrapu, BS, University of Illinois at Urbana-Champaign;
Brian M Sandroff, MS, University of Illinois at Urbana-Champaign;
Lara A Pilutti, PhD, University of Illinois at Urbana-Champaign;
Steve Morrison, PhD, Old Dominion Unviersity;
Robert W Motl, PhD, University of Illinois at Urbana-Champaign
Magnetic Resonance Imaging In The Cuprizone-Induced Demyelination Model
Rui Chang, BS, EMD Serono Research Institute Inc.;
Shuning Huang, PhD, EMD Serono Research Institute Inc.;
Anneli Savinainen, MS, EMD Serono Research Institute Inc.;
Tim Crandall, BS, EMD Serono Research Institute Inc.;
Danielle Graham, PhD, EMD Serono Research Institute Inc.;
Joseph Mandeville, PhD, Athinoula A. Martinos Center for Biomedical Imaging - MGH;
Ji-Kyung Choi, PhD, Athinoula A. Martinos Center for Biomedical Imaging - MGH;
Bruce Jenkins, PhD, Athinoula A. Martinos Center for Biomedical Imaging - MGH;
Guangping Dai, PhD, Athinoula A. Martinos Center for Biomedical Imaging - MGH;
Tammy Dellovade, PhD, EMD Serono Research Institute Inc.
Co-Existing PML-IRIS and Myelitis In Neuromyelitis Optica Spectrum Disorder
Eoin P Flanagan, MB.BCh, Mayo Clinic;
Allen J Aksamit, MD, Mayo Clinic;
Neeraj Kumar, MD, Mayo Clinic;
Neha P Morparia, MD, Mayo Clinic;
B Mark Keegan, MD, Mayo Clinic;
Brian G Weinshenker, MD, Mayo Clinic
Reliability, Precision and Clinically Meaningful Change Of Fatigue Outcomes In MS
Yvonne C Learmonth, PhD, University of Illinois at Urbana-Champaign;
Deirdre Dlugonski, BS, University of Illinois at Urbana-Champaign;
Lara A Pilutti, PhD, University of Illinois at Urbana-Champaign;
Brian M Sandroff, MS, University of Illinois at Urbana-Champaign;
Robert W Motl, PhD, University of Illinois at Urbana-Champaign;
Rachel E Klaren, BS, University of Illinois at Urbana-Champaign
2-Year Follow-Up Results Of The HALT MS Clinical Trial (ITN033AI)
Richard A Nash, MD, Colorado Blood Cancer Institute at PSL;
George J Hutton, MD, Baylor College of Medicine;
Michael K Racke, MD, The Ohio State University Wexner Medical Center;
Uday Popat, MD, MD Anderson Cancer Center;
Steven M Devine, MD, The Ohio State University Wexner Medical Center;
George E Georges, MD, Fred Hutchinson Cancer Research Center;
Linda M Griffith, MD PhD, National Institute of Allergy and Infectious Diseases, National Institutes of Health;
Paolo A Muraro, MD, Imperial College;
Harry Openshaw, MD, City of Hope National Medical Center;
Peter Sayre, MD, Immune Tolerance Network;
Olaf Stuve, MD, University of Texas Southwestern Medical Center at Dallas;
Douglas L Arnold, MD, Montreal Neurological Institute, McGill University, and NeuroRx Research, Montreal, Quebec, Canada;
Meagan Spychala, DrPH, Rho Federal Systems Division, Inc;
Noha Lim, PhD, Immune Tolerance Network;
Sachin Malhotra, PhD, Immune Tolerance Network;
Deborah Phippard, PhD, Immune Tolerance Network;
Annette Wundes, MD, University of Washington;
George H Kraft, MD, University of Washington;
James D Bowen, MD, Swedish Medical Center
Quantifying Balance and Its Relationship To Walking In Multiple Sclerosis
Scott D Newsome, D.O., Johns Hopkins School of Medicine;
Rhul Marasigan, B.A., Kennedy Krieger Institute;
Peter A Calabresi, MD, FAAN, Johns Hopkins School of Medicine;
Kathleen M Zackowski, PhD, OT, Kennedy Krieger Institute
Military Deployment and Risk For Multiple Sclerosis In The First Gulf War
Mitchell T Wallin, MD, MPH, MS Center of Excellence;
Clare Mahan, PhD, Office of Public Health, Department of Veterans Affairs;
Heidi Maloni, PhD, MS Center of Excellence;
William J Culpepper II, PhD, MA, Baltimore VAMC;
Parisa Coffman, BA, MS Center of Excellence;
John F Kurtzke, MD, Georgetown University
Leflunomide/Teriflunomide Differential Effects - Mitochondria and Hepatotoxicity
Emma-Jane Poulton, PhD, Sanofi;
Timothy Ackerson, MS, Sanofi;
Jacquelyn Dwyer, BS, Sanofi;
Sandrine Turpault, PharmD, Sanofi;
Lijuan Wang, PhD, Sanofi;
Lynn Davenport, PhD, DABT, Sanofi;
Zaid Jayyosi, PhD, Sanofi
Activated iNKT cells control CNS autoimmunity in a mechanism that involves MDSCs
Vrajesh V Parekh, Ph. D., Vanderbilt Medical Center;
Lan Wu, M. D., Vanderbilt Medical Center;
Danyvid Olivares-Villagomez, Ph. D., Vanderbilt Medical Center;
Keith Wilson, M. D. , Ph. D., Vanderbilt Medical Center;
Luc Van Kaer, Ph. D., Vanderbilt Medical Center
Effects Of Exercise Training On Fatigue In Multiple Sclerosis: A Meta-Analysis
Lara A Pilutti, PhD, University of Illinois at Urbana-Champaign;
Tina Greenlee, MS, University of Illinois at Urbana-Champaign;
Robert W Motl, PhD, University of Illinois at Urbana-Champaign;
Megan Nickrent, MS, University of Illinois at Urbana-Champaign;
Steven J Petruzzello, PhD, University of Illinois at Urbana-Champaign
Relative Efficacy of Teriflunomide 14 mg in Relapsing MS: A Mixed-Treatment Comparison
Gary Cutter, PhD, University of Alabama;
Kyle Fahrbach, PhD, United BioSource Corporation;
Rachel Huelin, BA, United BioSource Corporation;
Erika Wissinger, PhD, United BioSource Corporation;
Brice Kitio-Dschassi, X, Sanofi;
Catherine Dive-Pouletty, PharmD, Sanofi;
Patrick Vermersch, MD, PhD, University of Lille Nord de France
Cost-Effectiveness of Alemtuzumab for Relapsing-Remitting Multiple Sclerosis
Christine G. Kohn, PharmD, University of Connecticut;
Victoria Costales, MD, Griffin Hospital;
Craig I Coleman, PharmD, University of Connecticut;
Dan Young, PharmD, University of Connecticut;
Brendan L Limone, PharmD, University of Connecticut
Effect of Interferon Beta-1a SC on Demyelination in Multiple Sclerosis Patients
Robert Zivadinov, MD, PhD, FAAN, State University of New York at Buffalo, Buffalo;
Michael G Dwyer, MSc, State University of New York at Buffalo, Buffalo;
Silva Markovic-Plese, MD, PhD, University of North Carolina at Chapel Hill;
Cheryl Kennedy, LMSW, MPH, State University of New York at Buffalo, Buffalo;
Niels Bergsland, MS, State University of New York at Buffalo, Buffalo;
Deepa P Ramasamy, MD, State University of New York at Buffalo, Buffalo;
Jacqueline Durfee, BS, State University of New York at Buffalo, Buffalo;
David Hojnacki, MD, State University of New York at Buffalo, Buffalo;
Brooke Hayward, SM, MBA,, EMD Serono, Inc.;
Fernando Dangond, MD, FAAN, EMD Serono, Inc.;
Bianca Weinstock-Guttman, MD, State University of New York at Buffalo, Buffalo
Chemical Exchange Saturation Transfer Imaging in Multiple Sclerosis
Craig Jones, PhD, Kennedy Krieger Institute;
Chase Figley, BSc, Johns Hopkins University;
Peter van Zijl, PhD, Johns Hopkins University;
Peter A Calabresi, MD, FAAN, Johns Hopkins School of Medicine;
Susan Courtney, PhD, Johns Hopkins University
Interferon-Beta Reduces Mitochondrial Distress in EAE
Tapas K Makar, Ph.D., VA Maryland Health Care System;
Vamshi Nimmagadda, M.B.B.S., University of Maryland School of Medicine;
David Trisler, Ph.D., University of Maryland School of Medicine;
Susan I Judge, Ph.D., University of Maryland School of Medicine;
Naveen K Nagalla, MBBS, University of Maryland School of Medicine;
Christopher T Bever Jr., M.D., M.B.A., VA Maryland Health Care System
Sirtuin 1 in Experimental Allergic Encephalomyelitis
Vamshi Nimmagadda, M.B.B.S., University of Maryland School of Medicine;
Tapas K Makar, Ph.D., University of Maryland School of Medicine;
James W Russell, M.D., University of Maryland School of Medicine;
Krish Chandrasekaran, Ph.D., University of Maryland School of Medicine;
David Trisler, Ph.D., University of Maryland School of Medicine;
Susan I Judge, Ph.D., VA Maryland Health Care System;
Naveen K Nagalla, MBBS, University of Maryland School of Medicine;
Christopher T Bever Jr., M.D., M.B.A., University of Maryland School of Medicine
Effect of Interferon Beta-1a SC on Lesion Iron Content in Multiple Sclerosis
Robert Zivadinov, MD, PhD, FAAN, State University of New York at Buffalo, Buffalo;
Silva Markovic-Plese, MD, PhD, University of North Carolina at Chapel Hill;
Michael G Dwyer, MSc, State University of New York at Buffalo, Buffalo;
Brooke Hayward, SM, MBA,, EMD Serono, Inc.;
Niels Bergsland, MS, State University of New York at Buffalo, Buffalo;
Mari Heininen-Brown, BA, State University of New York at Buffalo, Buffalo;
Ellen Carl, MS, State University of New York at Buffalo, Buffalo;
Cheryl Kennedy, LMSW, MPH, State University of New York at Buffalo, Buffalo;
Fernando Dangond, MD, FAAN, EMD Serono, Inc.;
Bianca Weinstock-Guttman, MD, State University of New York at Buffalo, Buffalo
Intracortical Inhibition (ICI) and Facilitation (ICF) in Multiple Sclerosis (MS)
Marjan Zakeri, MD, The University of British Columbia;
Alex MacKay, PhD, The University of British Columbia;
Irene Vavasour, PhD, The University of British Columbia;
Anthony L. Traboulsee, MD, The University of British Columbia;
Lara Boyd, Phd, The University of British Columbia
Clinical Outcomes and MS Diagnosis Criteria in the Combirx Trial
Khurram Bashir, MD, MPH, The University of Alabama at Birmingham;
Stacey S Cofield, PhD, University of Alabama at Birmingham;
Gary Cutter, PhD, University of Alabama at Birmingham;
Jerry Wolinsky, MD, The University of Texas Health Science Center at Houston;
Tarah Gustafson, BSN, Corinne Goldsmith Dickinson Center for Multiple Sclerosis;
Robin Conwit, MD, NIH;
Amber Salter, MPH, University of Alabama at Birmingham;
Jing Wang, MS, University of Alabama at Birmingham;
Fred D. Lublin, MD, Corinne Goldsmith Dickinson Center for Multiple Sclerosis
Unexpected Retinal Abnormalities Detected Upon Evaluation for Neurological Disease
Elias S Sotirchos, MD, Johns Hopkins University;
Angela Vidal-Jordana, MD, Vall d’Hebron University Hospital;
Shiv Saidha, MD, Johns Hopkins University;
Yasir Sepah, MBBS, Johns Hopkins University;
John N Ratchford, MD, Johns Hopkins University;
Quan Dong Nguyen, MD, Johns Hopkins University;
Elliot Frohman, MD, PhD, FAAN, UT Southwestern Medical Center;
Laura J Balcer, MD, MSCE, New York University;
Peter A Calabresi, MD, FAAN, Johns Hopkins University;
Scott D Newsome, D.O., Johns Hopkins University
HHV6 IgG Response and Genetic Factor rs11154801 Associate With Relapse Rate in Children
Jennifer Graves, MD, PhD, University of California, San Francisco;
Lisa Barcellos, PhD, University of California, Berkeley;
Lauren Krupp, MD, Stony Brook University Medical Center;
Anita L Belman, MD, Stony Brook University Medical Center;
Judith A James, MD, Oklahoma Medical Research Foundation, University of Oklahoma;
Emmanuelle Waubant, MD, PhD, University of California, San Francisco
Determining Response to Treatment With Rituximab in Relapsing Multiple Sclerosis
Enrique Alvarez, MD/PhD, Washington University School of Medicine in St. Louis;
Laura Piccio, MD/PhD, Washington University School of Medicine in St. Louis;
Robert J Mikesell, BS, Washington University School of Medicine in St. Louis;
Kim Trinkaus, PhD, Washington University School of Medicine in St. Louis;
Nhial Tutlam, MPH, Washington University School of Medicine in St. Louis;
Michael J Ramsbottom, BS, Washington University School of Medicine in St. Louis;
Neville Rapp, PhD, Washington University School of Medicine in St. Louis;
Samantha Lancia, MS, Washington University School of Medicine in St. Louis;
Becky J Parks, MD, Washington University School of Medicine in St. Louis;
Robert T Naismith, MD, Washington University School of Medicine in St. Louis;
Anne H Cross, MD, Washington University School of Medicine in St. Louis
Circumstances Surrounding Falls in Individuals With Multiple Sclerosis
Moira Baynes, RN, Johns Hopkins University;
Scott D Newsome, D.O., Johns Hopkins School of Medicine;
Dorlan Kimbrough, MD, Johns Hopkins University;
Peter A Calabresi, MD, FAAN, Johns Hopkins University;
Kathleen M Zackowski, PhD, OT, Johns Hopkins School of Medicine
![[ Visit Client Website ]](images/banner.gif)